{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:40:02Z","timestamp":1792024802201,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4150,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/labinvest.2011.86","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T10:44:26Z","timestamp":1308566666000},"page":"1383-1395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["A polymeric nanoparticle formulation of curcumin (NanoCurc\u2122) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation"],"prefix":"10.1016","volume":"91","author":[{"given":"Savita","family":"Bisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtab A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena","family":"Bekhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A","family":"Rudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarnath","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balmiki","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debomoy","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2011.86_bib1","first-page":"361","article-title":"Molecular pathogenesis of liver fibrosis","volume":"120","author":"Brenner","year":"2009","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1038\/labinvest.2011.86_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","article-title":"The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo","volume":"30","author":"Hellerbrand","year":"1999","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2011.86_bib3","first-page":"222","article-title":"Cancer risk and diet in India","volume":"49","author":"Sinha","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1038\/labinvest.2011.86_bib4","first-page":"5941","article-title":"Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate","volume":"48","author":"Huang","year":"1988","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2011.86_bib5","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/0006-2952(76)90421-4","article-title":"Antioxidant activity of curcumin and related compounds","volume":"25","author":"Sharma","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2011.86_bib6","first-page":"574","article-title":"Anti-inflammatory activity of curcumin analogues","volume":"75","author":"Rao","year":"1982","journal-title":"Indian J Med Res"},{"key":"10.1038\/labinvest.2011.86_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.1995.1076","article-title":"Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages","volume":"206","author":"Brouet","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/labinvest.2011.86_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","article-title":"Antidepressant activity of curcumin: involvement of serotonin and dopamine system","volume":"201","author":"Kulkarni","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1038\/labinvest.2011.86_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2005.06.002","article-title":"The effects of curcumin on depressive-like behaviors in mice","volume":"518","author":"Xu","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/labinvest.2011.86_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/mol.107.039818","article-title":"Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation","volume":"73","author":"Fu","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1038\/labinvest.2011.86_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1211\/0022357001774048","article-title":"Protective effect of curcumin in rat liver injury induced by carbon tetrachloride","volume":"52","author":"Park","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"10.1038\/labinvest.2011.86_bib12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0006-2952(90)90603-I","article-title":"Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes","volume":"39","author":"Donatus","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2011.86_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2007-969845","article-title":"Antihepatotoxic principles of Curcuma longa rhizomes","volume":"49","author":"Kiso","year":"1983","journal-title":"Planta Med"},{"key":"10.1038\/labinvest.2011.86_bib14","doi-asserted-by":"crossref","first-page":"G20","DOI":"10.1152\/ajpgi.00474.2002","article-title":"Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth","volume":"285","author":"Xu","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Part 1","key":"10.1038\/labinvest.2011.86_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/BJ20040928","article-title":"Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro","volume":"384","author":"Zheng","year":"2004","journal-title":"Biochem J"},{"key":"10.1038\/labinvest.2011.86_bib16","first-page":"226","article-title":"Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts","volume":"14","author":"Kidd","year":"2009","journal-title":"Altern Med Rev"},{"key":"10.1038\/labinvest.2011.86_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00280-006-0355-x","article-title":"Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine","volume":"60","author":"Marczylo","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1038\/labinvest.2011.86_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","article-title":"Biotransformation of curcumin through reduction and glucuronidation in mice","volume":"27","author":"Pan","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/labinvest.2011.86_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-0-387-46401-5_20","article-title":"Pharmacokinetics and pharmacodynamics of curcumin","volume":"595","author":"Sharma","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/labinvest.2011.86_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1038\/labinvest.2011.86_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1055-9965.120.14.1","article-title":"Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences","volume":"14","author":"Garcea","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/labinvest.2011.86_bib22","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1535-7163.MCT-10-0172","article-title":"Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer","volume":"9","author":"Bisht","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/labinvest.2011.86_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bjc.6601623","article-title":"Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration","volume":"90","author":"Garcea","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1038\/labinvest.2011.86_bib24","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2011.86_bib25","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1158\/1535-7163.MCT-08-0476","article-title":"In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities","volume":"7","author":"Bisht","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/labinvest.2011.86_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-3155-5-3","article-title":"Polymeric nanoparticle-encapsulated curcumin (\u2018nanocurcumin'): a novel strategy for human cancer therapy","volume":"5","author":"Bisht","year":"2007","journal-title":"J Nanobiotechnology"},{"key":"10.1038\/labinvest.2011.86_bib27","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4049\/jimmunol.175.2.1295","article-title":"Contribution of the lymphotoxin beta receptor to liver regeneration","volume":"175","author":"Anders","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2011.86_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-2275(20)32030-7","article-title":"An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro","volume":"41","author":"Vogel","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1038\/labinvest.2011.86_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-46401-5_1","article-title":"Curcumin: the Indian solid gold","volume":"595","author":"Aggarwal","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/labinvest.2011.86_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/157016309789054933","article-title":"Systemic delivery of curcumin: 21st century solutions for an ancient conundrum","volume":"6","author":"Bisht","year":"2009","journal-title":"Curr Drug Discov Technol"},{"key":"10.1038\/labinvest.2011.86_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cyto.2004.11.001","article-title":"Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice","volume":"29","author":"Sudo","year":"2005","journal-title":"Cytokine"},{"key":"10.1038\/labinvest.2011.86_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","article-title":"Mechanisms of immune-mediated liver injury","volume":"115","author":"Adams","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1038\/labinvest.2011.86_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001574-200311000-00009","article-title":"Innate immunity in the liver","volume":"19","author":"Li","year":"2003","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1038\/labinvest.2011.86_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-991511","article-title":"Innate immune response and hepatic inflammation","volume":"27","author":"Szabo","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1038\/labinvest.2011.86_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00281-009-0169-0","article-title":"Mononuclear cells in liver fibrosis","volume":"31","author":"Marra","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1038\/labinvest.2011.86_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.03936.x","article-title":"Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes","volume":"157","author":"Ginsburg","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.2011.86_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(10)60105-5","article-title":"CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.","author":"Ishikawa","year":"2010","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2011.86_bib38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.22813","article-title":"Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride","volume":"49","author":"Park","year":"2009","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.86_bib39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/intimm\/dxm069","article-title":"Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution","volume":"19","author":"Safadi","year":"2007","journal-title":"Int Immunol"},{"key":"10.1038\/labinvest.2011.86_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2011.86_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.86_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1189\/jlb.0407247","article-title":"Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice","volume":"83","author":"Daley","year":"2008","journal-title":"J Leukocyte Biol"},{"key":"10.1038\/labinvest.2011.86_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark","year":"2009","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.86_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2006-927387","article-title":"Mouse models of liver fibrosis","volume":"45","author":"Weiler-Normann","year":"2007","journal-title":"Z Gastroenterol"},{"key":"10.1038\/labinvest.2011.86_bib45","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1172\/JCI111621","article-title":"Relationship of oxygen and glutathione in protection against carbon tetrachloride-induced hepatic microsomal lipid peroxidation and covalent binding in the rat. Rationale for the use of hyperbaric oxygen to treat carbon tetrachloride ingestion","volume":"74","author":"Burk","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2011.86_bib46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bj2150441","article-title":"Reduced glutathione protection against rat liver microsomal injury by carbon tetrachloride. Dependence on O2","volume":"215","author":"Burk","year":"1983","journal-title":"Biochem J"},{"key":"10.1038\/labinvest.2011.86_bib47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2007.04.016","article-title":"De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation","volume":"43","author":"Zheng","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/labinvest.2011.86_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02934504","article-title":"Molecular mechanisms of hepatic fibrosis and principles of therapy","volume":"32","author":"Friedman","year":"1997","journal-title":"J Gastroenterol"},{"key":"10.1038\/labinvest.2011.86_bib49","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: the principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2011.86_bib50","first-page":"183","article-title":"Collagen production by rat liver fat-storing cells in primary culture","volume":"54","author":"Kawase","year":"1986","journal-title":"Exp Cell Biol"},{"key":"10.1038\/labinvest.2011.86_bib51","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0016-5085(92)91522-6","article-title":"Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines","volume":"103","author":"Ramadori","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.86_bib52","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0016-5085(95)90211-2","article-title":"Accumulation and cellular localization of fibrinogen\/fibrin during short-term and long-term rat liver injury","volume":"108","author":"Neubauer","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.86_bib53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.510290346","article-title":"Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C\/EBPbeta-dependent mechanism in rat hepatic stellate cells","volume":"29","author":"Garcia-Trevijano","year":"1999","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.86_bib54","first-page":"S39","article-title":"Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis","volume":"54","author":"Gressner","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/labinvest.2011.86_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.510310117","article-title":"Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells","volume":"31","author":"Galli","year":"2000","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.86_bib56","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.86_bib57","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2011.86_bib58","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/labinvest.2009.115","article-title":"Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress","volume":"89","author":"Lin","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2011.86_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1038\/labinvest.2011.86_bib60","series-title":"The Burden of Digestive Diseases in the United States","author":"Everhart","year":"2008"},{"key":"10.1038\/labinvest.2011.86_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/17425247.3.2.205","article-title":"Multi-functional polymeric nanoparticles for tumour-targeted drug delivery","volume":"3","author":"van Vlerken","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1038\/labinvest.2011.86_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tibtech.2005.11.006","article-title":"Polymer conjugates: nanosized medicines for treating cancer","volume":"24","author":"Vicent","year":"2006","journal-title":"Trends Biotechnol"},{"key":"10.1038\/labinvest.2011.86_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/153303460500400405","article-title":"Targeted drug delivery in cancer therapy","volume":"4","author":"Vasir","year":"2005","journal-title":"Technol Cancer Res Treat"},{"key":"10.1038\/labinvest.2011.86_bib64","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1002\/jps.22157","article-title":"Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation","volume":"99","author":"Ganta","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1038\/labinvest.2011.86_bib65","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ejmech.2007.10.034","article-title":"Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues","volume":"43","author":"Appiah-Opong","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1038\/labinvest.2011.86_bib66","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1124\/dmd.108.020552","article-title":"Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor","volume":"36","author":"Volak","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/labinvest.2011.86_bib67","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/labinvest.2008.20","article-title":"Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells","volume":"88","author":"Lin","year":"2008","journal-title":"Lab Invest"},{"issue":"Suppl 1","key":"10.1038\/labinvest.2011.86_bib68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","article-title":"Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts","volume":"26","author":"Jaeschke","year":"2011","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201186","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722027337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722027337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:52:20Z","timestamp":1758397940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722027337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0023683722027337"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2011.86","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A polymeric nanoparticle formulation of curcumin (NanoCurc\u2122) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2011.86","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}